| UniProt ID | STK24_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y6E0 | |
| Protein Name | Serine/threonine-protein kinase 24 | |
| Gene Name | STK24 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 443 | |
| Subcellular Localization | Cytoplasm. Nucleus. Membrane. The truncated form (MST3/N) translocates to the nucleus. Colocalizes with STK38L in the membrane. | |
| Protein Description | Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its kinase activity. In association with STK26 negatively regulates Golgi reorientation in polarized cell migration upon RHO activation. [PubMed: 27807006 Regulates also cellular migration with alteration of PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and inhibits its activity and may regulate PXN phosphorylation through PTPN12. May act as a key regulator of axon regeneration in the optic nerve and radial nerve.] | |
| Protein Sequence | MDSRAQLWGLALNKRRATLPHPGGSTNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDSSSEDSDAETDGQASGGSDSGDWIFTIREKDPKNLENGALQPSDLDRNKMKDIPKRPFSQCLSTIISPLFAELKEKSQACGGNLGSIEELRGAIYLAEEACPGISDTMVAQLVQRLQRYSLSGGGTSSH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 (in isoform 2) | Acetylation | - | 46.99 | 19369195 | |
| 4 (in isoform 2) | Phosphorylation | - | 23.30 | 25159151 | |
| 8 (in isoform 2) | Phosphorylation | - | 6.41 | 22617229 | |
| 18 | Phosphorylation | ALNKRRATLPHPGGS HHHCCCCCCCCCCCC | 38.72 | 10644707 | |
| 25 (in isoform 2) | Phosphorylation | - | 21.75 | 26270265 | |
| 38 | Ubiquitination | DPEELFTKLEKIGKG CHHHHHHHHHHHCCC | 47.52 | - | |
| 44 | Ubiquitination | TKLEKIGKGSFGEVF HHHHHHCCCCHHHHC | 55.65 | - | |
| 46 | Phosphorylation | LEKIGKGSFGEVFKG HHHHCCCCHHHHCCC | 33.30 | 20873877 | |
| 52 | Ubiquitination | GSFGEVFKGIDNRTQ CCHHHHCCCCCCCCC | 61.20 | 21890473 | |
| 52 (in isoform 1) | Ubiquitination | - | 61.20 | 21890473 | |
| 52 | Ubiquitination | GSFGEVFKGIDNRTQ CCHHHHCCCCCCCCC | 61.20 | - | |
| 59 (in isoform 2) | Ubiquitination | - | 33.05 | 21890473 | |
| 93 | Phosphorylation | LSQCDSPYVTKYYGS HHCCCCCCHHCCCCC | 25.38 | - | |
| 113 | Phosphorylation | KLWIIMEYLGGGSAL EEEEEEEHHCCCCHH | 8.02 | - | |
| 142 | Ubiquitination | TILREILKGLDYLHS HHHHHHHHHHHHHHC | 64.19 | - | |
| 142 | Malonylation | TILREILKGLDYLHS HHHHHHHHHHHHHHC | 64.19 | 26320211 | |
| 151 | Ubiquitination | LDYLHSEKKIHRDIK HHHHHCCCHHHHCHH | 61.10 | - | |
| 152 | Ubiquitination | DYLHSEKKIHRDIKA HHHHCCCHHHHCHHH | 39.43 | - | |
| 175 (in isoform 2) | Ubiquitination | - | 7.63 | - | |
| 182 | Phosphorylation | FGVAGQLTDTQIKRN EEECCCCCCCCHHHC | 29.16 | 30266825 | |
| 184 | Phosphorylation | VAGQLTDTQIKRNTF ECCCCCCCCHHHCCC | 27.27 | 22322096 | |
| 187 | Ubiquitination | QLTDTQIKRNTFVGT CCCCCCHHHCCCCCC | 29.76 | - | |
| 190 | Phosphorylation | DTQIKRNTFVGTPFW CCCHHHCCCCCCCCC | 24.59 | 22322096 | |
| 194 | Phosphorylation | KRNTFVGTPFWMAPE HHCCCCCCCCCCCHH | 15.26 | 30266825 | |
| 237 | Sulfoxidation | PHSELHPMKVLFLIP CCCCCCCCEEEEEEC | 3.06 | 30846556 | |
| 238 | Ubiquitination | HSELHPMKVLFLIPK CCCCCCCEEEEEECC | 39.99 | 21890473 | |
| 238 (in isoform 1) | Ubiquitination | - | 39.99 | 21890473 | |
| 238 | Ubiquitination | HSELHPMKVLFLIPK CCCCCCCEEEEEECC | 39.99 | 21890473 | |
| 245 (in isoform 2) | Ubiquitination | - | 63.46 | 21890473 | |
| 245 | Ubiquitination | KVLFLIPKNNPPTLE EEEEEECCCCCCCCC | 63.46 | - | |
| 256 | Phosphorylation | PTLEGNYSKPLKEFV CCCCCCCCHHHHHHH | 31.62 | 24719451 | |
| 257 | Ubiquitination | TLEGNYSKPLKEFVE CCCCCCCHHHHHHHH | 43.97 | - | |
| 278 | Ubiquitination | PSFRPTAKELLKHKF CCCCCCHHHHHHCHH | 51.91 | - | |
| 280 (in isoform 2) | Ubiquitination | - | 8.33 | - | |
| 292 | 2-Hydroxyisobutyrylation | FILRNAKKTSYLTEL HHHHCCCCHHHHHHH | 40.05 | - | |
| 292 | Ubiquitination | FILRNAKKTSYLTEL HHHHCCCCHHHHHHH | 40.05 | 2189047 | |
| 292 (in isoform 1) | Ubiquitination | - | 40.05 | 21890473 | |
| 292 | Malonylation | FILRNAKKTSYLTEL HHHHCCCCHHHHHHH | 40.05 | 26320211 | |
| 292 | Ubiquitination | FILRNAKKTSYLTEL HHHHCCCCHHHHHHH | 40.05 | 21890473 | |
| 293 | Phosphorylation | ILRNAKKTSYLTELI HHHCCCCHHHHHHHH | 23.15 | 28152594 | |
| 294 | Phosphorylation | LRNAKKTSYLTELID HHCCCCHHHHHHHHH | 27.33 | 28152594 | |
| 295 | Phosphorylation | RNAKKTSYLTELIDR HCCCCHHHHHHHHHH | 23.91 | 28152594 | |
| 297 | Phosphorylation | AKKTSYLTELIDRYK CCCHHHHHHHHHHHH | 22.10 | 28152594 | |
| 299 (in isoform 2) | Ubiquitination | - | 4.09 | 21890473 | |
| 303 | Phosphorylation | LTELIDRYKRWKAEQ HHHHHHHHHHHHHHH | 10.93 | - | |
| 311 | Phosphorylation | KRWKAEQSHDDSSSE HHHHHHHCCCCCCCC | 22.01 | 18691976 | |
| 315 | Phosphorylation | AEQSHDDSSSEDSDA HHHCCCCCCCCCCCC | 41.65 | 17081983 | |
| 316 | Phosphorylation | EQSHDDSSSEDSDAE HHCCCCCCCCCCCCC | 44.75 | 17081983 | |
| 317 | Phosphorylation | QSHDDSSSEDSDAET HCCCCCCCCCCCCCC | 49.74 | 17081983 | |
| 320 | Phosphorylation | DDSSSEDSDAETDGQ CCCCCCCCCCCCCCC | 34.37 | 12107159 | |
| 324 | Phosphorylation | SEDSDAETDGQASGG CCCCCCCCCCCCCCC | 47.34 | 28857561 | |
| 329 | Phosphorylation | AETDGQASGGSDSGD CCCCCCCCCCCCCCC | 35.48 | 25841592 | |
| 340 | Phosphorylation | DSGDWIFTIREKDPK CCCCEEEEEEECCCC | 15.25 | 24719451 | |
| 347 | Ubiquitination | TIREKDPKNLENGAL EEEECCCCCCCCCCC | 81.79 | - | |
| 373 | Phosphorylation | DIPKRPFSQCLSTII CCCCCCHHHHHHHHH | 23.75 | 26074081 | |
| 377 | Phosphorylation | RPFSQCLSTIISPLF CCHHHHHHHHHHHHH | 25.78 | 26074081 | |
| 378 | Phosphorylation | PFSQCLSTIISPLFA CHHHHHHHHHHHHHH | 14.91 | 26074081 | |
| 381 | Phosphorylation | QCLSTIISPLFAELK HHHHHHHHHHHHHHH | 16.23 | 28450419 | |
| 390 | Ubiquitination | LFAELKEKSQACGGN HHHHHHHHHHHCCCC | 46.40 | - | |
| 400 | Phosphorylation | ACGGNLGSIEELRGA HCCCCCCCHHHHHHH | 29.96 | 26657352 | |
| 433 | Phosphorylation | LVQRLQRYSLSGGGT HHHHHHHHCCCCCCC | 10.87 | - | |
| 434 | Phosphorylation | VQRLQRYSLSGGGTS HHHHHHHCCCCCCCC | 20.46 | 28555341 | |
| 436 | Phosphorylation | RLQRYSLSGGGTSSH HHHHHCCCCCCCCCC | 29.47 | 23090842 | |
| 440 | Phosphorylation | YSLSGGGTSSH---- HCCCCCCCCCC---- | 30.26 | 26434776 | |
| 441 | Phosphorylation | SLSGGGTSSH----- CCCCCCCCCC----- | 29.68 | 28985074 | |
| 442 | Phosphorylation | LSGGGTSSH------ CCCCCCCCC------ | 32.81 | 22617229 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 18 | T | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
| 18 | T | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 18 | T | Phosphorylation | Kinase | PKA | - | Uniprot |
| 18 | T | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| 190 | T | Phosphorylation | Kinase | STK24 | Q9Y6E0 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 190 | T | Phosphorylation |
| 17046825 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STK24_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-311; SER-315; SER-316;SER-317 AND SER-320, AND MASS SPECTROMETRY. | |
| "Structures of human MST3 kinase in complex with adenine, ADP andMn2+."; Ko T.P., Jeng W.Y., Liu C.I., Lai M.D., Wu C.L., Chang W.J., Shr H.L.,Lu T.J., Wang A.H.; Acta Crystallogr. D 66:145-154(2010). Cited for: X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 27-315 IN COMPLEX WITHADENINE; ADP AND MANGANESE IONS, SUBUNIT, AND PHOSPHORYLATION ATTHR-190. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-190, AND MASSSPECTROMETRY. | |
| "Mammalian sterile 20-like kinase 3 (MST3) mediates oxidative-stress-induced cell death by modulating JNK activation."; Chen C.B., Ng J.K., Choo P.H., Wu W., Porter A.G.; Biosci. Rep. 29:405-415(2009). Cited for: FUNCTION, AND PHOSPHORYLATION AT THR-190. | |
| "Inhibition of cell migration by autophosphorylated mammalian sterile20-like kinase 3 (MST3) involves paxillin and protein-tyrosinephosphatase-PEST."; Lu T.J., Lai W.Y., Huang C.Y., Hsieh W.J., Yu J.S., Hsieh Y.J.,Chang W.T., Leu T.H., Chang W.C., Chuang W.J., Tang M.J., Chen T.Y.,Lu T.L., Lai M.D.; J. Biol. Chem. 281:38405-38417(2006). Cited for: FUNCTION, PHOSPHORYLATION AT THR-190, AND MUTAGENESIS OF THR-190. | |
| "Identification of a human brain-specific isoform of mammalian STE20-like kinase 3 that is regulated by cAMP-dependent protein kinase."; Zhou T.-H., Ling K., Guo J., Zhou H., Wu Y.-L., Jing Q., Ma L.,Pei G.; J. Biol. Chem. 275:2513-2519(2000). Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), PHOSPHORYLATION AT THR-18,MUTAGENESIS OF THR-18, AND VARIANT VAL-414. | |